The Study of Biomarkers of Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease in the Relationship with the Severity of Shortness of Breath and Indicators of the Quality of Life of Patients

##plugins.themes.bootstrap3.article.main##

Бен Аммар Сауссен
О. С. Коміссарова
Н. В. Кіча
Л. В. Черкашина

Abstract

The objective: to study the levels of biomarkers of systemic inflammation (IL-8 and TNF-α) in patients with chronic obstructive pulmonary disease (COPD) in conjunction with the severity of shortness of breath and indicators of the impact of the disease on the quality of life of patients.

Materials and methods. The study involved 120 patients with COPD: 115 men and 5 women (average age – 58.5 ± 4.1 years). All patients were active smokers. Patients were hospitalized for exacerbation of COPD in theKharkov city pulmonology center. Diagnosis and treatment of patients is performed in accordance with current clinical protocols.

Results. The relationship between the severity of dyspnea and the level of biomarkers of systemic inflammation is characterized by the undulating character of the level of biomarkers of systemic inflammation, which indicates their different pathogenetic significance at the stages of evelopment of COPD.

Conclusion. It was revealed that the nature and severity of changes in the levels of biomarkers of systemic inflammation is interrelated with the severity of shortness of breath and indicators of the influence of COPD on the quality of life of patients. An analysis of the relative indices of IL-8 and TNF-α in relation to the degree of dyspnea revealed that with a 2nd degree of severity of dyspnea, an increase (1.5 times) in the content of TNF-α is more informative, and with a 3rd degree, an increase ( 1.4 times) the level of blood levels of IL-8. It was revealed that the increasing influence of COPD on the quality of life of patients is characterized by a stable tendency to an increase in the blood content of IL-8 with a relatively stable level of TNF-α.

##plugins.themes.bootstrap3.article.details##

How to Cite
Сауссен, Б. А., Коміссарова, О. С., Кіча, Н. В., & Черкашина, Л. В. (2019). The Study of Biomarkers of Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease in the Relationship with the Severity of Shortness of Breath and Indicators of the Quality of Life of Patients. Family Medicine, (5-6), 105–108. https://doi.org/10.30841/2307-5112.5-6.2019.194300
Section
Internal diseases
Author Biographies

Бен Аммар Сауссен, Kharkiv Medical Academy of Postgraduate Education

Ben Ammar Saussen

О. С. Коміссарова, P.L. Shupyk National Medical Academy of Postgraduate Education

Olha S. Komissarova,

Department of Family Medicine

Н. В. Кіча, P.L. Shupyk National Medical Academy of Postgraduate Education

Nataliia V. Kicha,

Department of Family Medicine

Л. В. Черкашина, V. N. Karazin Kharkiv National University, Kharkiv Medical Academy of Postgraduate Education

Lidiia V. Cherkashina,

Department of Family Medicine, Folk and Non-traditional Medicine, Sanology at the Kharkiv Medical Academy of Postgraduate Education

References

Приказ МЗ Украины от 19.03.2007 г. № 128 «Об утверждении клинических протоколов оказания медицинской помощи по специальности «Пульмонология».

Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета программ Statistica. – М.: МедиаСфера, 2006. – 212 с.

Barnes P. Pulmonary biomarkers in chronic obstructive pulmonary disease / P. Barnes, B. Chowdhury, S. Kharitonov // Am. J. Respir. Crit. Care Med., 2006. – V. 174. – P. 6–14.

Dahl M.J. Nordestgaard: C – reactive protein as a predictor of prognosis in COPD / M.J. Dahl, P. Vestbo, S.E. Lange // Am. J. Resp. Crit. Care Med., 2007. – Vol. 175. – P. 250–255.

Donaldson G.C. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease / G.C. Donaldson, T.A. Seemungal, A. Bhowmik // Thorax, 2002. – V. 57. – Р. 847–852.

Foreman M.G. Clinical determinants of exacerbations in severe, early onset COPD / M.G. Foreman, D.L. DeMeo, C.P. Hersh // Eur. Respir. J., 2007. – V. 30 (6). – Р. 1124–1130.

Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary // Am. J. Respir. Crit. Care Med., 2011. – V. 176 (6). – Р. 532–555.

Ilyin S.E. Biomarker discovery and validation:technologies and integrative approaches / S.E. Ilyin, S.M. Belkowski, C.R. Plata-Salamán // Trends Biotechnol., 2004. – V. 22. – Р. 411–416.

Patel I.S. Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbations / I.S. Patel, T.A.R. Seemungal, M. Wilks // Thorax, 2002. – V. 178 (8). – Р. 332–227.

Sevenoaks M.J. Chronic оbstructive рulmonary disease, inflamation and comorbidity – a common inflammatory phenolype? / M.J. Sevenoaks, R.A. Stockley // Respir. Res., 2006. – Vol. 7. – Р. 70.